HLA B27 Flow Cytometry

• Test Name: HLA B27 Flow Cytometry Test
• Test Type: Immunophenotyping using flow cytometry
• Specimen Required: Whole blood sample (usually collected in an EDTA tube)
• Methodology: Flow cytometry is used to detect the presence of HLA B27 on the surface of white blood cells. The test uses antibodies that bind specifically to the HLA B27 antigen and measures fluorescence intensity to identify positive cells.
• Purpose: Identifies the presence of the HLA B27 protein, which is associated with certain autoimmune conditions, especially ankylosing spondylitis and other inflammatory diseases.

• Diagnosis: Helps diagnose autoimmune diseases like ankylosing spondylitis, reactive arthritis, and other spondyloarthropathies that are associated with the HLA B27 antigen.
• Risk Assessment: Identifies individuals who may have a genetic predisposition to develop certain autoimmune diseases.
• Screening: Assists in screening patients with symptoms of inflammatory back pain or uveitis for HLA B27-associated diseases.

• Antigen Detection: Detects the presence of the HLA B27 antigen on white blood cells using monoclonal antibodies.
• Flow Cytometry: A laser-based technique that measures how cells react to fluorescently labeled antibodies.
• Quantification: Provides a qualitative positive or negative result for HLA B27.

• Positive Result: A positive result indicates the presence of the HLA B27 antigen, which increases the likelihood of developing conditions like ankylosing spondylitis, though not definitive on its own for diagnosis.
• Negative Result: A negative result means the HLA B27 antigen is not present, reducing the likelihood of HLA B27-related autoimmune diseases.
• Clinical Correlation: The presence of HLA B27 alone does not confirm a disease but suggests a higher risk, especially when correlated with clinical symptoms.

• Turnaround Time: Results are typically available within 1-3 days.
• Reporting: Results are usually reported as either positive (presence of HLA B27) or negative (absence of HLA B27).
• Follow-up Testing: Positive results may lead to further clinical assessment, imaging, or specific autoimmune disorder testing to confirm or rule out a diagnosis.
• Actionable Outcomes: A positive result may guide the clinical approach in managing symptoms or preventing disease progression through early intervention.

Q. What is the HLA B27 Flow Cytometry Test?
This test detects the HLA B27 protein on white blood cells using flow cytometry. It is used primarily to assess the risk for autoimmune diseases like ankylosing spondylitis
 

Q. Why would I need an HLA B27 Flow Cytometry Test?
This test is commonly ordered if you have symptoms of inflammatory back pain, arthritis, or uveitis to help diagnose conditions associated with the HLA B27 antigen
 

Q. How is the HLA B27 Flow Cytometry Test performed?
A blood sample is taken and analyzed using flow cytometry to detect the presence of HLA B27 by measuring fluorescence from antibodies binding to the antigen
 

Q. What does a positive HLA B27 test mean?
A positive result means that you carry the HLA B27 antigen, which is associated with a higher risk for certain autoimmune conditions, but it does not guarantee that you will develop them
 

Q. Can I have a negative HLA B27 test and still have an autoimmune condition?
Yes, you can have a negative HLA B27 test and still have autoimmune conditions, as some people with autoimmune diseases do not carry the HLA B27 antigen
 

Q. Do I need to prepare for the HLA B27 Flow Cytometry Test?
No special preparation is needed for the test, but it's important to inform your healthcare provider of any medications you are taking as they may affect immune function
 

Q. What happens if my HLA B27 test is positive?
A positive result may lead to further clinical evaluation, imaging, or monitoring for diseases like ankylosing spondylitis. Your doctor may recommend additional tests or treatments based on your symptoms